2012
DOI: 10.1016/j.clinbiochem.2012.03.022
|View full text |Cite
|
Sign up to set email alerts
|

Immature platelet fraction as marker for platelet recovery after stem cell transplantation in children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
6
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 12 publications
1
6
0
Order By: Relevance
“…In addition, these studies also reported high interindividual variations of studied parameters such as range 7–45 days of IRF >10% after HSCT , range 4–33 days/8–30 days of IRF/IPF recovery after HSCT , and interquartile range 14.9–22.8 days/7.1–11.9 days of IRF >12%/IPF >6% after allogeneic HSCT , which is consistent with our present study. A recent study also reported that although high IPF (%) is followed by platelet recovery in general, wide interindividual variations exist (range of period between the time point of IPF peak and platelet recovery, 1–13 days) and no recovery was also recorded in some patients, suggesting that IPF recovery is not a reliable marker for platelet recovery after HSCT . These results are consistent with our present study and underscore the lack of clinical usefulness of studied parameters in terms of wide interindividual variations, which is one of the main results of our present study.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…In addition, these studies also reported high interindividual variations of studied parameters such as range 7–45 days of IRF >10% after HSCT , range 4–33 days/8–30 days of IRF/IPF recovery after HSCT , and interquartile range 14.9–22.8 days/7.1–11.9 days of IRF >12%/IPF >6% after allogeneic HSCT , which is consistent with our present study. A recent study also reported that although high IPF (%) is followed by platelet recovery in general, wide interindividual variations exist (range of period between the time point of IPF peak and platelet recovery, 1–13 days) and no recovery was also recorded in some patients, suggesting that IPF recovery is not a reliable marker for platelet recovery after HSCT . These results are consistent with our present study and underscore the lack of clinical usefulness of studied parameters in terms of wide interindividual variations, which is one of the main results of our present study.…”
Section: Discussionsupporting
confidence: 89%
“…In hematopoietic stem cell transplantation (HSCT)‐performed patients, pancytopenia caused by chemotherapy increases mortality and the need for transfusion, which can increase the risk of transfusion‐related complications such as infection and hemolytic transfusion reaction. Therefore, it would be useful to identify parameters that predict the recovery of hematopoietic cells after HSCT in transplanted patients . The automated blood cell analyzer Sysmex XE‐2100 (Sysmex, Kobe, Japan) can quantitate hematopoietic stem and progenitor cells (HPC) using the immature myeloid information channel, and its suitability was validated .…”
Section: Introductionmentioning
confidence: 99%
“…They are important in various clinical situations, such as thrombocytopenia, anemia, bone marrow regeneration following the transplantation of hematopoietic stem cells and after chemotherapy 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13…”
Section: Introductionmentioning
confidence: 99%
“…These fractions are calculated during automated reticulocyte counting by blood analyzers and thus constitute a rapid, simple test that carries no additional cost as compared to a standard reticulocyte count. They have shown good results in the assessment of marrow recovery, thrombocytopenias, and erythropoiesis among other phenomena [10][11][12][13][14][15].…”
Section: Introductionmentioning
confidence: 99%